skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Elevated expression of CD93 promotes angiogenesis and tumor growth in nasopharyngeal carcinoma

Abstract

CD93, also known as the complement component C1q receptor (C1qRp), has been reported to promote the progression of some cancer types. However, the expression and physiological significance of CD93 in nasopharyngeal carcinoma (NPC) remain largely elusive. In this study, we first examined the expression of CD93 in NPC and experimentally manipulated its expression. We observed that vascular CD93 expression is elevated in NPC and is correlated with T classification, N classification, distant metastasis, clinical stage and poor prognosis (all P < 0.05). In addition, overexpression of CD93 promoted angiogenesis in vitro. What’s more, we found that CD93 was highly expressed in NPC tissues and cells, and the regulation of CD93 on cell proliferation was determined by cell counting kit (CCK)-8 assay and cell cycle analyses. Our findings provide unique insight into the pathogenesis of NPC and underscore the need to explore novel therapeutic targets such as CD93 to improve NPC treatment. -- Highlights: •This is the first research about the relationship between CD93 and nasopharyngeal carcinoma. •We explored the prognostic significance of vascular CD93 expression in nasopharyngeal carcinoma. •We researched on angiogenesis and cell proliferation of nasopharyngeal carcinoma and how CD93 affected them.

Authors:
 [1];  [2]; ; ; ; ;  [1];  [1];  [1]
  1. Department of Otorhinolaryngology Head and Neck Surgery, Affiliated Hospital of Nantong University, Nantong, Jiangsu Province (China)
  2. Department of Otorhinolaryngology Head and Neck Surgery, Affiliated Cancer Hospital of Nantong University, Nantong, 226361, Jiangsu (China)
Publication Date:
OSTI Identifier:
22598798
Resource Type:
Journal Article
Resource Relation:
Journal Name: Biochemical and Biophysical Research Communications; Journal Volume: 476; Journal Issue: 4; Other Information: Copyright (c) 2016 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.; Country of input: International Atomic Energy Agency (IAEA)
Country of Publication:
United States
Language:
English
Subject:
60 APPLIED LIFE SCIENCES; ANGIOGENESIS; ANIMAL TISSUES; CARCINOMAS; CELL CYCLE; CELL PROLIFERATION; IN VITRO; METASTASES; PATHOGENESIS; RECEPTORS

Citation Formats

Bao, Lili, Tang, Mingming, Zhang, Qicheng, You, Bo, Shan, Ying, Shi, Si, Li, Li, Hu, Songqun, E-mail: hsq@ntu.edu.cn, and You, Yiwen, E-mail: youyiwen_nantong@163.com. Elevated expression of CD93 promotes angiogenesis and tumor growth in nasopharyngeal carcinoma. United States: N. p., 2016. Web. doi:10.1016/J.BBRC.2016.05.146.
Bao, Lili, Tang, Mingming, Zhang, Qicheng, You, Bo, Shan, Ying, Shi, Si, Li, Li, Hu, Songqun, E-mail: hsq@ntu.edu.cn, & You, Yiwen, E-mail: youyiwen_nantong@163.com. Elevated expression of CD93 promotes angiogenesis and tumor growth in nasopharyngeal carcinoma. United States. doi:10.1016/J.BBRC.2016.05.146.
Bao, Lili, Tang, Mingming, Zhang, Qicheng, You, Bo, Shan, Ying, Shi, Si, Li, Li, Hu, Songqun, E-mail: hsq@ntu.edu.cn, and You, Yiwen, E-mail: youyiwen_nantong@163.com. Fri . "Elevated expression of CD93 promotes angiogenesis and tumor growth in nasopharyngeal carcinoma". United States. doi:10.1016/J.BBRC.2016.05.146.
@article{osti_22598798,
title = {Elevated expression of CD93 promotes angiogenesis and tumor growth in nasopharyngeal carcinoma},
author = {Bao, Lili and Tang, Mingming and Zhang, Qicheng and You, Bo and Shan, Ying and Shi, Si and Li, Li and Hu, Songqun, E-mail: hsq@ntu.edu.cn and You, Yiwen, E-mail: youyiwen_nantong@163.com},
abstractNote = {CD93, also known as the complement component C1q receptor (C1qRp), has been reported to promote the progression of some cancer types. However, the expression and physiological significance of CD93 in nasopharyngeal carcinoma (NPC) remain largely elusive. In this study, we first examined the expression of CD93 in NPC and experimentally manipulated its expression. We observed that vascular CD93 expression is elevated in NPC and is correlated with T classification, N classification, distant metastasis, clinical stage and poor prognosis (all P < 0.05). In addition, overexpression of CD93 promoted angiogenesis in vitro. What’s more, we found that CD93 was highly expressed in NPC tissues and cells, and the regulation of CD93 on cell proliferation was determined by cell counting kit (CCK)-8 assay and cell cycle analyses. Our findings provide unique insight into the pathogenesis of NPC and underscore the need to explore novel therapeutic targets such as CD93 to improve NPC treatment. -- Highlights: •This is the first research about the relationship between CD93 and nasopharyngeal carcinoma. •We explored the prognostic significance of vascular CD93 expression in nasopharyngeal carcinoma. •We researched on angiogenesis and cell proliferation of nasopharyngeal carcinoma and how CD93 affected them.},
doi = {10.1016/J.BBRC.2016.05.146},
journal = {Biochemical and Biophysical Research Communications},
number = 4,
volume = 476,
place = {United States},
year = {Fri Aug 05 00:00:00 EDT 2016},
month = {Fri Aug 05 00:00:00 EDT 2016}
}